Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 400INDUSTRY 123NIH 59NETWORK 37UNKNOWN 2OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Thoracic 1

Conditions

Glioblastoma 2

Interventions

Radiotherapy 4Blood Specimen Collection 3Ultrasonography 2Temozolomide 2Radiosurgery 2Pemetrexed 2Exercise 2pembrolizumab 1lithium sulfate 1ipatasertib 1dactolisib 1aumolertinib 1aflutinib 1Zinc 1Surgery, Computer-Assisted 1Standard of Care 1Quality of Life 1Pliability 1Photic Stimulation 1Observation 1Neuropsychological Tests 1Moxibustion 1Metformin 1Mental Status and Dementia Tests 1Magnetic Resonance Imaging 1Lomustine 1Lithium 1Hypoglycemic Agents 1Ga(III)-DOTATOC 1Duloxetine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Temozolomide × CNS × Clear all
NCT06419946 2026-04-13

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Vastra Gotaland Region

Phase 3 Recruiting
200 enrolled
CNS

Glioblastoma

NCT02029573 2017-08-18

ART

King Fahad Medical City

Phase 2 Completed
36 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡